Drug Discovery and Safety (DDS)
What is Drug Discovery and Safety?
The Drug Discovery and Safety (DDS) master programme is a research oriented master programme with a focus on drug development. The programme combines aspects of chemistry, pharmacology, medicine, genetics and toxicology and takes a multidisciplinary approach.
In the Drug Discovery and Safety programme you will be engaged in
- Characterization of new receptors or other proteins within the human body
- Computational modeling of biologically active compounds
- Synthesis of biologically active compounds
- Study the binding of biologically active compounds to receptors or other target proteins
- Study the cellular response of a ligand-receptor interaction
- Study the desired and undesired response of a ligand-receptor interaction
- Developing of new testing methods for all this
As a Drug Discovery and Safety student you will
- Acquire insights into the various aspects of the drug discovery and development processes
- Experience a good balance between group, pair and individual study
- Become an expert in one of the specializations in drug discovery and development
- Participate in internationally renowned research groups within the Department of Chemistry and Pharmaceutical Sciences:
Your profile
You are interested in one of the aspects of drug discovery and development. You have a background in molecular pharmacology, molecular toxicology or chemistry. Developing new drugs is such a complex and wide-ranging process that it requires real specialists that are excellent team players: people with a broad perspective and who will do their utmost to tackle the diseases of tomorrow in an interdisciplinary environment. If you recognize yourself in this profile, the master programme Drug Discovery & Safety will suit your interest.
-
Taal:
Engels
- Duur: 2 years
- Collegegeld: EU/EEA residents: € 1,713
non-EU/EEA residents: € 12,000 - Aanmelden voor: 1 April for non-EU/EEA students; 1 April for EU and EEA students; 1 July for Dutch students from institutions other than VU University Amsterdam
- Startdatum: 1 September 2012
- Vorm: Voltijd
- Interessegebied: Gezondheid en Beweging, Natuurwetenschappen
- Specialisaties:
Drug Discovery & Target Finding
Drug Disposition & Safety Assessment
Drug Design & Synthesis
Computational Medicinal Chemistry & Toxicology
Biomarkers & Clinical Chemical Analysis - Toelatingseisen: Language proficiency: TOEFL 580/237/92-93 or IELTS 6.5
